Rethinking lean metabolic dysfunction-associated steatotic liver disease: Unrecognized risk in lean populations: Editorial on “Normal-weight metabolic dysfunction-associated steatotic liver disease: Reclassification, characteristics, and adverse liver outcomes across diverse populations”

Clinical and Molecular Hepatology · Published 2026-01-27 · DOI 10.3350/cmh.2026.0056

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.3350/cmh.2026.0056

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year
2026

Related articles